Kelsey Carlson is named as a lobbyist on federal disclosure filings for 47 clients through Jeffrey J. Kimbell & Associates, Inc.. The most recent filing naming them posted in March 2026. Issues reported include Health Issues, Medicare/Medicaid, Trade (domestic/foreign) and Defense.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| BIOTISSUE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| LIVANOVA USA INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Environment/Superfund, Health Issues |
| WE WORK FOR HEALTH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| STERIS CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Environment/Superfund, Health Issues |
| ORGANON & CO. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SUPERNUS PHARMACEUTICALS INC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| INSTITUTE FOR GENE THERAPIES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| PHARMING HEALTHCARE, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| COLLEGIUM PHARMACEUTICAL | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| MOMENTOUS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Defense |
| ILLUMINA, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Defense |
| SCPHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Veterans |
| GENUS LIFESCIENCES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| ACCURAY INCORPORATED | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Trade (domestic/foreign) |
| GLAUKOS CORPORATION (FKA AVEDRO, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| TERUMO BCT | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Trade (domestic/foreign) |
| NEUROTECH PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| AMGEN INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SPARC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| NEVRO CORPORATION | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| ASTELLAS PHARMA US | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| BIOGEN INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| GILEAD SCIENCES, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| BROOKDALE SENIOR LIVING INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Housing, Health Issues |
| CATALYST PHARMACEUTICALS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| HARMONY BIOSCIENCES, LLC | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| ARDELYX, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| THE ALLERGY, ASTHMA & SINUS CENTER | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| U.S. RENAL CARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| THERAGEN, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid |
| AURION BIOTECH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Health Issues |
| SPARK THERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues, Insurance |
| EAGLE PHARMACEUTICALS INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q4 2024 | Medicare/Medicaid, Health Issues |
| SSI GROUP | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2024 | Health Issues |
| MASIMO | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2024 | Financial Institutions/Investments/Securities |
| ANIVIVE LIFESCIENCES | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2024 | Health Issues, Medical/Disease Research/Clinical Labs, Agriculture |
| REVANCE THERAPEUTICS INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2024 | Health Issues |
| LIFEWARD (FORMERLY REWALK ROBOTICS, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q2 2024 | Medicare/Medicaid |
| TEK84 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q1 2024 | Manufacturing, Tariff (miscellaneous tariff bills) |
| SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q1 2024 | Medicare/Medicaid, Health Issues |
| ENZYVANT THERAPEUTICS GMBH | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Health Issues |
| HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Medicare/Medicaid, Health Issues |
| IOR PARTNERS | JEFFREY J. KIMBELL & ASSOCIATES, INC. | Q3 2023 | Medicare/Medicaid |
| Year | Clients | Registrants |
|---|---|---|
| 2024 | 44 | 1 |
| 2023 | 39 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Kelsey Carlson. See the Capitol Clarity rankings and method.